BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 15501990)

  • 1. Aberrant methylation of DPYD promoter, DPYD expression, and cellular sensitivity to 5-fluorouracil in cancer cells.
    Noguchi T; Tanimoto K; Shimokuni T; Ukon K; Tsujimoto H; Fukushima M; Noguchi T; Kawahara K; Hiyama K; Nishiyama M
    Clin Cancer Res; 2004 Oct; 10(20):7100-7. PubMed ID: 15501990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methylation of the DPYD promoter: an alternative mechanism for dihydropyrimidine dehydrogenase deficiency in cancer patients.
    Ezzeldin HH; Lee AM; Mattison LK; Diasio RB
    Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8699-705. PubMed ID: 16361556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypermethylation of the DPYD promoter region is not a major predictor of severe toxicity in 5-fluorouracil based chemotherapy.
    Amstutz U; Farese S; Aebi S; Largiadèr CR
    J Exp Clin Cancer Res; 2008 Oct; 27(1):54. PubMed ID: 18937829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequence analysis of the 5'-flanking regions of human dihydropyrimidine dehydrogenase gene: identification of a new polymorphism related with effects of 5-fluorouracil.
    Hasegawa T; Kim HS; Fukushima M; Wataya Y
    Nucleosides Nucleotides Nucleic Acids; 2005; 24(4):233-42. PubMed ID: 16021908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activator protein accelerates dihydropyrimidine dehydrogenase gene transcription in cancer cells.
    Ukon K; Tanimoto K; Shimokuni T; Noguchi T; Hiyama K; Tsujimoto H; Fukushima M; Toge T; Nishiyama M
    Cancer Res; 2005 Feb; 65(3):1055-62. PubMed ID: 15705907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Dihydropyrimidine dehydrogenase activity and its genetic aberrations].
    Ogura K
    Gan To Kagaku Ryoho; 2006 Aug; 33(8):1041-8. PubMed ID: 16912518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two cases of 5-fluorouracil toxicity linked with gene variants in the DPYD gene.
    Ofverholm A; Arkblad E; Skrtic S; Albertsson P; Shubbar E; Enerbäck C
    Clin Biochem; 2010 Feb; 43(3):331-4. PubMed ID: 19822137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between chemosensitivity and mRNA expression level of 5-fluorouracil-related metabolic enzymes during liver metastasis of colorectal cancer.
    Okumura K; Shiomi H; Mekata E; Kaizuka M; Endo Y; Kurumi Y; Tani T
    Oncol Rep; 2006 Apr; 15(4):875-82. PubMed ID: 16525674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prediction of sensitivity to 5-fluorouracil (5-fu) by metabolic and target enzyme activities in colon cancer].
    Yamada T; Tanaka N; Yokoi K; Ishikawa N; Seya T; Horiba K; Kanazawa Y; Shirakawa T; Ohkawa K; Kudoh H; Koizumi M; Yoshioka M; Shinji S; Yamashita K; Tajiri T
    Gan To Kagaku Ryoho; 2006 Nov; 33(11):1603-9. PubMed ID: 17108726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of genetic and nongenetic factors for fluorouracil treatment-related severe toxicity: a prospective clinical trial by the German 5-FU Toxicity Study Group.
    Schwab M; Zanger UM; Marx C; Schaeffeler E; Klein K; Dippon J; Kerb R; Blievernicht J; Fischer J; Hofmann U; Bokemeyer C; Eichelbaum M;
    J Clin Oncol; 2008 May; 26(13):2131-8. PubMed ID: 18299612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of DPYD expression in RKO cells via DNA methylation in the regulatory region of the DPYD promoter: a potentially important epigenetic mechanism regulating DPYD expression.
    Zhang X; Soong R; Wang K; Li L; Davie JR; Guarcello V; Diasio RB
    Biochem Cell Biol; 2007 Jun; 85(3):337-46. PubMed ID: 17612628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-494 sensitizes colon cancer cells to fluorouracil through regulation of DPYD.
    Chai J; Dong W; Xie C; Wang L; Han DL; Wang S; Guo HL; Zhang ZL
    IUBMB Life; 2015 Mar; 67(3):191-201. PubMed ID: 25873402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Anti-tumor effects of various interferons-alpha +5-fluorouracil via downregulation of dihydropyrimidine dehydrogenase in hepatoma cells].
    Fan XY; Uchida H; Iwaki K; Kai S; Shibata K; Ohta M; Kitano S
    Gan To Kagaku Ryoho; 2007 Jun; 34(6):957-9. PubMed ID: 17565266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Up-regulation in dihydropyrimidine dehydrogenase activity by raltitrexed causes antagonism in combination with 5-fluorouracil.
    Nozoe Y; Ogata Y; Araki Y; Sasatomi T; Fukumori H; Shirouzu K
    Anticancer Res; 2003; 23(6C):4663-9. PubMed ID: 14981911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cloning and initial characterization of the human DPYD gene promoter.
    Collie-Duguid ES; Johnston SJ; Powrie RH; Milano G; Etienne MC; Rochat B; Watson GC; McLeod HL
    Biochem Biophys Res Commun; 2000 Apr; 271(1):28-35. PubMed ID: 10777676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long noncoding RNA LINC00261 induces chemosensitization to 5-fluorouracil by mediating methylation-dependent repression of DPYD in human esophageal cancer.
    Lin K; Jiang H; Zhuang SS; Qin YS; Qiu GD; She YQ; Zheng JT; Chen C; Fang L; Zhang SY
    FASEB J; 2019 Feb; 33(2):1972-1988. PubMed ID: 30226808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dihydropyrimidine dehydrogenase activity in 150 healthy Japanese volunteers and identification of novel mutations.
    Ogura K; Ohnuma T; Minamide Y; Mizuno A; Nishiyama T; Nagashima S; Kanamaru M; Hiratsuka A; Watabe T; Uematsu T
    Clin Cancer Res; 2005 Jul; 11(14):5104-11. PubMed ID: 16033824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical implications of dihydropyrimidine dehydrogenase (DPD) activity in 5-FU-based chemotherapy: mutations in the DPD gene, and DPD inhibitory fluoropyrimidines.
    Omura K
    Int J Clin Oncol; 2003 Jun; 8(3):132-8. PubMed ID: 12851836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dihydropyrimidine dehydrogenase (DPD) expression is negatively regulated by certain microRNAs in human lung tissues.
    Hirota T; Date Y; Nishibatake Y; Takane H; Fukuoka Y; Taniguchi Y; Burioka N; Shimizu E; Nakamura H; Otsubo K; Ieiri I
    Lung Cancer; 2012 Jul; 77(1):16-23. PubMed ID: 22306127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dihydropyrimidine dehydrogenase expression predicts survival outcome and chemosensitivity to 5-fluorouracil in patients with oral squamous cell carcinoma.
    Kobayashi H; Koike T; Nakatsuka A; Kurita H; Sagara J; Taniguchi S; Kurashina K
    Oral Oncol; 2005 Jan; 41(1):38-47. PubMed ID: 15598584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.